LNAI logo

LNAI

Lunai Bioworks Inc.NASDAQHealthcare
$0.37-24.40%ClosedMarket Cap: $6.6M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

PEG

P/B

-0.49

P/S

0.00

EV/EBITDA

-0.95

DCF Value

$-1.32

FCF Yield

-114.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-1241.3%

ROA

-1882.9%

ROIC

116.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q2 2025$0.00$-1.8M$-0.08
Q1 2025$0.00$2.8M$0.13
Q4 2024$0.00$-126.7M$-7.61
FY 2024$0.00$-178.0M$-10.78

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NASDAQ

Beta

0.49

A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.

Peers